|
COLL | Collegium Pharmaceutical, Inc |
|
|
COLL | Collegium Pharmaceutical, Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.19 |
| Leverage | 82.90% |
| Market Cap | $ 1.5B |
| PE | 25.51 |
| Dividend Yield | 0.00% |
| Profit | $ 58.1m |
| Margin | 7.70% |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.